top of page
Medical Checkup

ATLAS

Trial Enrolment Status

OPEN

Disease Under Study

ASTHMA

Duration

~3 Years

About the Trial

Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Patients With Uncontrolled Moderate to Severe Asthma

Mechanism of Action:

Anti IL-4

Dr. George Philteos

Principal Investigator

Dr. George Philteos

Sub-Investigator

Dr. Anushya Chelvanathan

Study Coordinator

Nusrat Jahan

bottom of page